Irenic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESGR
Enstar Group
ESGR
|
+$8.42M |
| 2 |
Outfront Media
OUT
|
+$7.93M |
| 3 |
Diebold Nixdorf
DBD
|
+$7.66M |
| 4 |
James River Group Holdings
JRVR
|
+$6.55M |
| 5 |
Sotera Health
SHC
|
+$6.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARNC
Arconic Corporation
ARNC
|
+$10.6M |
| 2 |
ENFN
Enfusion, Inc.
ENFN
|
+$9.86M |
| 3 |
News Corp Class A
NWSA
|
+$3.23M |
| 4 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
+$88.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 54.49% |
| 2 | Healthcare | 12.61% |
| 3 | Technology | 5.6% |
| 4 | Financials | 4.06% |
| 5 | Real Estate | 2.68% |
Similar funds
Irenic Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Irenic Capital Management held 25 positions worth $352M, up 5.2% from $335M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Irenic Capital Management deployed $31.1M of net new capital in Q3 2023, opening 13 new positions and adding to 2 existing holdings. Its largest new stake was Enstar Group: 33,547 shares worth $8.12M.
By sector, the portfolio is most concentrated in Communication Services at 54% of assets, up from 54% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Enfusion, Inc., an estimated $9.86M trimmed.
- Irenic Capital Management's largest Q3 2023 buy was Enstar Group: 33,547 shares worth $8.12M.
- Irenic Capital Management added most to Sotera Health in Q3 2023, an estimated $6.33M increase.
- Irenic Capital Management's biggest Q3 2023 reduction was Enfusion, Inc., cutting an estimated $9.86M.
- Irenic Capital Management fully exited Arconic Corporation in Q3 2023, selling an estimated $10.6M.
- Irenic Capital Management's ten largest holdings make up 86% of its $352M portfolio in Q3 2023.
- Irenic Capital Management opened 13 new positions and closed 2 in Q3 2023.
- Irenic Capital Management's portfolio value rose 5.2% quarter-over-quarter to $352M.
Based on Irenic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.